Halozyme Therapeutics Inc (HALO)
45.70
-0.06
(-0.13%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.12
(+0.26%)
After-Hours: 20:00
Halozyme Therapeutics Total Assets (Quarterly): 2.118B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.118B |
| June 30, 2024 | 1.969B |
| March 31, 2024 | 1.842B |
| December 31, 2023 | 1.733B |
| September 30, 2023 | 1.893B |
| June 30, 2023 | 1.810B |
| March 31, 2023 | 1.699B |
| December 31, 2022 | 1.842B |
| September 30, 2022 | 1.865B |
| June 30, 2022 | 1.781B |
| March 31, 2022 | 1.162B |
| December 31, 2021 | 1.104B |
| September 30, 2021 | 1.185B |
| June 30, 2021 | 1.026B |
| March 31, 2021 | 966.58M |
| December 31, 2020 | 579.92M |
| September 30, 2020 | 524.03M |
| June 30, 2020 | 527.00M |
| March 31, 2020 | 492.35M |
| December 31, 2019 | 565.87M |
| September 30, 2019 | 370.36M |
| June 30, 2019 | 417.83M |
| March 31, 2019 | 429.11M |
| December 31, 2018 | 440.25M |
| September 30, 2018 | 444.51M |
| Date | Value |
|---|---|
| June 30, 2018 | 474.75M |
| March 31, 2018 | 495.47M |
| December 31, 2017 | 519.94M |
| September 30, 2017 | 357.15M |
| June 30, 2017 | 344.79M |
| March 31, 2017 | 226.77M |
| December 31, 2016 | 261.52M |
| September 30, 2016 | 282.50M |
| June 30, 2016 | 296.13M |
| March 31, 2016 | 309.10M |
| December 31, 2015 | 181.79M |
| September 30, 2015 | 158.73M |
| June 30, 2015 | 174.05M |
| March 31, 2015 | 159.12M |
| December 31, 2014 | 165.98M |
| September 30, 2014 | 164.63M |
| June 30, 2014 | 182.05M |
| March 31, 2014 | 197.69M |
| December 31, 2013 | 101.79M |
| September 30, 2013 | 110.15M |
| June 30, 2013 | 107.39M |
| March 31, 2013 | 116.87M |
| December 31, 2012 | 134.73M |
| September 30, 2012 | 107.98M |
| June 30, 2012 | 121.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
492.35M
Minimum
Mar 2020
2.118B
Maximum
Sep 2024
1.334B
Average
1.442B
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 74.36B |
| Novavax Inc | 1.712B |
| Insulet Corp | 3.025B |
| BioLife Solutions Inc | 381.65M |
| TransMedics Group Inc | 785.57M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.665B |
| Shareholders Equity (Quarterly) | 452.70M |
| Debt to Equity Ratio | 3.323 |
| Current Ratio | 10.36 |
| Net Debt Paydown Yield | -0.02% |